This inventor holds 4 USPTO granted patents, plus 3 CIPO patents and 2 EPO patents. Top assignees: Laboratoire Medidom Sa, Other. Active years: 2008-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008-2010
Title: Antonello Pietrangelo: Innovator in Pharmaceutical Chemistry
Introduction
Antonello Pietrangelo is a notable inventor based in Modena, Italy. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 4 patents, his work focuses on advancements that can impact medical treatments and diagnostics.
Latest Patents
One of his latest patents is titled "Esters of hyaluronic acid with rhein, process for their preparation and compositions comprising the same." This invention relates to esters of hyaluronic acid where the alcohol groups are esterified with rhein. It also includes a process for preparing this ester and a pharmaceutical composition that incorporates it. Another significant patent is "Mutations in the SLC40A1 gene associated to impaired iron homeostasis." This invention addresses mutations in the SLC40A1 gene, which are linked to impaired iron homeostasis and hereditary diseases. It also outlines methods for diagnosing these conditions based on the identification of the mutations.
Career Highlights
Throughout his career, Antonello has worked with various companies, including Laboratoire Medidom Sa. His expertise in pharmaceutical chemistry has allowed him to develop innovative solutions that address critical health issues.
Collaborations
Antonello has collaborated with notable professionals in his field, including Valter Travagli. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Antonello Pietrangelo is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect a commitment to improving medical treatments and diagnostics, showcasing his impact on the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile